AU4497199A - Cd4 radio-immunological pharmaceuticals for the treatment of hiv infections - Google Patents

Cd4 radio-immunological pharmaceuticals for the treatment of hiv infections

Info

Publication number
AU4497199A
AU4497199A AU44971/99A AU4497199A AU4497199A AU 4497199 A AU4497199 A AU 4497199A AU 44971/99 A AU44971/99 A AU 44971/99A AU 4497199 A AU4497199 A AU 4497199A AU 4497199 A AU4497199 A AU 4497199A
Authority
AU
Australia
Prior art keywords
radio
treatment
hiv infections
immunological
pharmaceuticals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU44971/99A
Inventor
Ingrid-Corina Bergter
Wolfgang Bergter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1998126307 external-priority patent/DE19826307A1/en
Application filed by Individual filed Critical Individual
Publication of AU4497199A publication Critical patent/AU4497199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
AU44971/99A 1998-04-15 1999-04-15 Cd4 radio-immunological pharmaceuticals for the treatment of hiv infections Abandoned AU4497199A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19826307 1998-04-15
DE1998126307 DE19826307A1 (en) 1998-03-08 1998-04-15 CD4 radio immunological pharmaceuticals
PCT/DE1999/001177 WO1999054954A2 (en) 1998-04-15 1999-04-15 Cd4 radio-immunological pharmaceuticals for the treatment of hiv infections

Publications (1)

Publication Number Publication Date
AU4497199A true AU4497199A (en) 1999-11-08

Family

ID=7870747

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44971/99A Abandoned AU4497199A (en) 1998-04-15 1999-04-15 Cd4 radio-immunological pharmaceuticals for the treatment of hiv infections

Country Status (5)

Country Link
EP (1) EP1071475A2 (en)
JP (1) JP2002512261A (en)
AU (1) AU4497199A (en)
DE (1) DE19980721D2 (en)
WO (1) WO1999054954A2 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0491873A4 (en) * 1989-09-14 1992-10-28 Board Of Regents, The University Of Texas System Therapeutic compositions; methods for treatment of hiv infections
CA2049964A1 (en) * 1990-01-26 1991-07-27 Mark P. Pasek C4 binding protein fusion proteins
GB9217124D0 (en) * 1992-08-13 1992-09-23 Antisoma Ltd Medical treatment
AU6483896A (en) * 1995-07-07 1997-02-10 The Texas A & M University System Nucleotide and amino acid sequence and uses thereof
DE19809785C2 (en) * 1998-03-08 2000-02-10 Wolfgang Bergter Radioimmune drug for the treatment of HIV-1 infection

Also Published As

Publication number Publication date
DE19980721D2 (en) 2001-03-29
JP2002512261A (en) 2002-04-23
EP1071475A2 (en) 2001-01-31
WO1999054954A2 (en) 1999-10-28
WO1999054954A3 (en) 2000-01-20

Similar Documents

Publication Publication Date Title
HUP0001539A3 (en) 2-(1-iminoethylamino)ethyl-homocysteine, process for its preparation and pharmaceutical compositions containing the same
AU6405198A (en) Plant for the treatment of products, which includes means for characterizing the products
HK1047575A1 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containingthe same.
IL139002A0 (en) Compositions for the treatment of hiv and other viral infections
AU3813499A (en) The use of dihydropyrimidines as medicaments, and novel substances
ZA965752B (en) Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents.
EP0604182A3 (en) Inhibitors of HIV protease useful for the treatment of Aids.
AU3118200A (en) Hiv integrase inhibitors
AU6616400A (en) Hiv integrase inhibitors
AU7973994A (en) Combination therapy for hiv infection
AU6062498A (en) Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use
AU1285300A (en) Hiv vaccine
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
AU2759800A (en) Processes and intermediates for the preparation of 1,3-oxazin-6-ones and uracils
AU6119699A (en) Highly branched oligomers, process for their preparation and applications thereof
AU1408300A (en) Hiv infection inhibitors
AU8009900A (en) Hiv integrase inhibitors
AU4135493A (en) Inhibitors of HIV protease useful for the treatment of AIDS
AU5252993A (en) Inhibitors of HIV protease useful for the treatment of AIDS
AU2021601A (en) Composition for the treatment of dandruff
AU3814599A (en) Use of erythropoietin for the treatment of haemochromatoses
EP1143990A3 (en) Pharmaceutical compostions comprising peg-asparaginase for the treatment of hiv infections
AU4145999A (en) Topical drug for the treatment of viral infections
AU5494298A (en) Pharmaceutical compositions for the treatment of the eye
AU4497199A (en) Cd4 radio-immunological pharmaceuticals for the treatment of hiv infections

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase